• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疟疾疫苗设计:免疫学考虑。

Malaria vaccine design: immunological considerations.

机构信息

Division of Immunology, The Queensland Institute of Medical Research, Brisbane, QLD 4006, Australia.

出版信息

Immunity. 2010 Oct 29;33(4):555-66. doi: 10.1016/j.immuni.2010.10.005.

DOI:10.1016/j.immuni.2010.10.005
PMID:21029965
Abstract

The concept of a malaria vaccine has sparked great interest for decades; however, the challenge is proving to be a difficult one. Immune dysregulation by Plasmodium and the ability of the parasite to mutate critical epitopes in surface antigens have proved to be strong defense weapons. This has led to reconsideration of polyvalent and whole parasite strategies and ways to enhance cellular immunity to malaria that may be more likely to target conserved antigens and an expanded repertoire of antigens. These and other concepts will be discussed in this review.

摘要

疟疾疫苗的概念几十年来一直引起人们的极大兴趣;然而,事实证明这是一个艰巨的挑战。疟原虫的免疫失调和寄生虫突变表面抗原关键表位的能力已被证明是强大的防御武器。这导致人们重新考虑多价和全寄生虫策略,并寻找增强疟疾细胞免疫的方法,这可能更有可能针对保守抗原和扩大的抗原谱。在这篇综述中,将讨论这些和其他概念。

相似文献

1
Malaria vaccine design: immunological considerations.疟疾疫苗设计:免疫学考虑。
Immunity. 2010 Oct 29;33(4):555-66. doi: 10.1016/j.immuni.2010.10.005.
2
The immunological challenge to developing a vaccine to the blood stages of malaria parasites.开发针对疟原虫血液阶段疫苗所面临的免疫学挑战。
Immunol Rev. 2004 Oct;201:254-67. doi: 10.1111/j.0105-2896.2004.00178.x.
3
Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.用于预防恶性疟原虫疟疾的红细胞前期疟疾疫苗。
Chem Immunol. 2002;80:253-61.
4
IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.在约氏疟原虫模型中,IL-12和自然杀伤细胞是由CD8 + T细胞引发的针对疟疾的抗原特异性适应性免疫所必需的。
J Immunol. 1999 Jul 15;163(2):884-92.
5
Malaria vaccine development using synthetic peptides as a technical platform.基于合成肽技术平台的疟疾疫苗研发。
Adv Immunol. 2012;114:107-49. doi: 10.1016/B978-0-12-396548-6.00005-6.
6
Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.将疟疾DNA疫苗的抗原靶向主要组织相容性复合体I类和II类抗原呈递途径。
Immunol Lett. 2007 Aug 15;111(2):92-102. doi: 10.1016/j.imlet.2007.05.007. Epub 2007 Jun 18.
7
Progress in DNA-based heterologous prime-boost immunization strategies for malaria.基于DNA的疟疾异源初免-加强免疫策略的进展
Immunol Rev. 2004 Jun;199:126-43. doi: 10.1111/j.0105-2896.2004.00138.x.
8
Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.基于亚基的多抗原、多阶段化学合成疫苗的新规则
Acc Chem Res. 2008 Mar;41(3):377-86. doi: 10.1021/ar700120t. Epub 2008 Feb 12.
9
Exoerythrocytic malaria vaccine development: understanding host-parasite immunobiology underscores strategic success.红细胞外期疟疾疫苗的研发:理解宿主-寄生虫免疫生物学是战略成功的关键。
Expert Rev Vaccines. 2002 Oct;1(3):317-40. doi: 10.1586/14760584.1.3.317.
10
Preerythrocytic malaria vaccine development.疟原虫前体细胞疫苗的研发。
Curr Opin Infect Dis. 2007 Oct;20(5):461-6. doi: 10.1097/QCO.0b013e3282ef6172.

引用本文的文献

1
A landscape review of malaria vaccine candidates in the pipeline.对正在研发的疟疾疫苗候选物的全景综述。
Trop Dis Travel Med Vaccines. 2024 Aug 1;10(1):19. doi: 10.1186/s40794-024-00222-3.
2
Live Vaccination with Blood-Stage 17XNL Prevents the Development of Experimental Cerebral Malaria.用血期17XNL活疫苗预防实验性脑型疟疾的发生。
Vaccines (Basel). 2022 May 11;10(5):762. doi: 10.3390/vaccines10050762.
3
Plasmodium falciparum merozoite surface protein 3 as a vaccine candidate: a brief review.恶性疟原虫裂殖子表面蛋白 3 作为疫苗候选抗原:简要综述。
Rev Inst Med Trop Sao Paulo. 2022 Mar 11;64:e23. doi: 10.1590/S1678-9946202264023. eCollection 2022.
4
Global diversity and balancing selection of 23 leading Plasmodium falciparum candidate vaccine antigens.全球 23 种主要恶性疟原虫候选疫苗抗原的多样性和平衡选择。
PLoS Comput Biol. 2022 Feb 2;18(2):e1009801. doi: 10.1371/journal.pcbi.1009801. eCollection 2022 Feb.
5
Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites.利用嵌合鼠疟原虫筛选疟原虫前体期候选疫苗抗原。
PLoS One. 2021 Jul 12;16(7):e0254498. doi: 10.1371/journal.pone.0254498. eCollection 2021.
6
Hydroethanolic Extract from Müll. Arg. Bark Improves Haematological and Biochemical Parameters in Nicotinamide-/Streptozotocin-Induced Diabetic Rats.来自穆勒氏(Müll. Arg.)树皮的乙醇提取物改善烟酰胺/链脲佐菌素诱导的糖尿病大鼠的血液学和生化参数。
Evid Based Complement Alternat Med. 2020 Nov 25;2020:3160834. doi: 10.1155/2020/3160834. eCollection 2020.
7
Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria.疟原虫 LSA1 和 LSAP2 融合抗原的病毒载体的临床前开发和评估,以提高抗肝期疟疾的疗效。
Infect Immun. 2020 Jan 22;88(2). doi: 10.1128/IAI.00573-19.
8
Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge.表达疟原虫 knowlesi 抗原的巨细胞病毒载体诱导免疫应答,在疟原虫子孢子挑战时延迟寄生虫血症。
PLoS One. 2019 Jan 23;14(1):e0210252. doi: 10.1371/journal.pone.0210252. eCollection 2019.
9
Proteome-wide mapping of immune features onto Plasmodium protein three-dimensional structures.对疟原虫蛋白质三维结构进行免疫特征的蛋白质组学全谱分析。
Sci Rep. 2018 Mar 12;8(1):4355. doi: 10.1038/s41598-018-22592-3.
10
Comparative functional potency of DNA vaccines encoding Plasmodium falciparum transmission blocking target antigens Pfs48/45 and Pfs25 administered alone or in combination by in vivo electroporation in rhesus macaques.经体内电穿孔单独或联合给药时,编码疟原虫传播阻断靶抗原 Pfs48/45 和 Pfs25 的 DNA 疫苗在恒河猴中的比较功能效力。
Vaccine. 2017 Dec 15;35(50):7049-7056. doi: 10.1016/j.vaccine.2017.10.042. Epub 2017 Nov 10.